We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
10 Year Est. Return
AUM
$227M
AUM Growth
+$24.9M
Cap. Flow
+$27.3M
Cap. Flow %
12.01%
Top 10 Hldgs %
56.79%
Holding
56
New
8
Increased
32
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$10.8M
2
APTV icon
Aptiv
APTV
+$9.82M
3
AAPL icon
Apple
AAPL
+$733K
4
RH icon
RH
RH
+$574K
5
EXPD icon
Expeditors International
EXPD
+$508K

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$232K
2
MMM icon
3M
MMM
+$207K
3
KOPN icon
Kopin
KOPN
+$175K
4
KEYS icon
Keysight
KEYS
+$116K
5
CPRT icon
Copart
CPRT
+$25.8K

Sector Composition

Rank Sector Weight
1 Industrials 37.67%
2 Technology 18.47%
3 Financials 15.2%
4 Consumer Discretionary 10.94%
5 Healthcare 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$634B
$710K 0.31%
8,131
+350
+4% +$32K
AMZN icon
27
Amazon
AMZN
$2.96T
$522K 0.23%
4,620
+460
+11% +$58.1K
ABBV icon
28
AbbVie
ABBV
$435B
$436K 0.19%
3,250
+500
+18% +$71.7K
CTVA icon
29
Corteva
CTVA
$51.3B
$420K 0.18%
7,356
MSFT icon
30
Microsoft
MSFT
$3.71T
$419K 0.18%
1,800
+100
+6% +$26.4K
AMGN icon
31
Amgen
AMGN
$222B
$417K 0.18%
1,850
+400
+28% +$97K
RTX icon
32
RTX Corp
RTX
$301B
$371K 0.16%
4,529
+116
+3% +$10.5K
PFE icon
33
Pfizer
PFE
$153B
$367K 0.16%
8,397
+500
+6% +$24.3K
ACN icon
34
Accenture
ACN
$108B
$347K 0.15%
+1,350
New +$390K
STZ icon
35
Constellation Brands
STZ
$23.2B
$316K 0.14%
1,375
+50
+4% +$12.2K
CSCO icon
36
Cisco
CSCO
$479B
$300K 0.13%
7,500
UNP icon
37
Union Pacific
UNP
$174B
$297K 0.13%
1,525
UPS icon
38
United Parcel Service
UPS
$88.9B
$291K 0.13%
1,800
-119
-6% -$22.5K
V icon
39
Visa
V
$677B
$285K 0.13%
1,605
+250
+18% +$50.9K
WELL icon
40
Welltower
WELL
$171B
$267K 0.12%
+4,150
New +$324K
XLU icon
41
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$262K 0.12%
+8,000
New +$293K
ABT icon
42
Abbott
ABT
$187B
$261K 0.11%
2,700
+300
+13% +$32K
KO icon
43
Coca-Cola
KO
$375B
$255K 0.11%
4,544
+200
+5% +$12.4K
APTV.PRA
44
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
$246K 0.11%
+2,580
New +$288K
ITW icon
45
Illinois Tool Works
ITW
$85.3B
$239K 0.11%
1,325
CMP icon
46
Compass Minerals
CMP
$1.15B
$237K 0.1%
+6,150
New +$234K
CRM icon
47
Salesforce
CRM
$158B
$227K 0.1%
1,575
+125
+9% +$21.2K
MAR icon
48
Marriott International
MAR
$92.3B
$221K 0.1%
1,575
AMT icon
49
American Tower
AMT
$80.4B
$220K 0.1%
+1,025
New +$263K
SO icon
50
Southern Company
SO
$107B
$204K 0.09%
3,000

Similar funds

Weybosset Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, Weybosset Research & Management held 56 positions worth $227M, up 12% from $202M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Weybosset Research & Management deployed $27.3M of net new capital in Q3 2022, opening 8 new positions and adding to 32 existing holdings. Its largest new stake was Canadian National Railway: 90,272 shares worth $9.75M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Keysight, an estimated $116K trimmed.

  • Weybosset Research & Management's largest Q3 2022 buy was Canadian National Railway: 90,272 shares worth $9.75M.
  • Weybosset Research & Management added most to Apple in Q3 2022, an estimated $733K increase.
  • Weybosset Research & Management's biggest Q3 2022 reduction was Keysight, cutting an estimated $116K.
  • Weybosset Research & Management fully exited McDonald's in Q3 2022, selling an estimated $232K.
  • Weybosset Research & Management's ten largest holdings make up 57% of its $227M portfolio in Q3 2022.
  • Weybosset Research & Management opened 8 new positions and closed 3 in Q3 2022.
  • Weybosset Research & Management's portfolio value rose 12% quarter-over-quarter to $227M.

Based on Weybosset Research & Management's 13F filing for Q3 2022, filed 7 Nov 2022.